BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36798020)

  • 1. Outcomes of Wilms tumor therapy in Lilongwe, Malawi, 2016-2021: Successes and ongoing research priorities.
    Holmes DM; Matatiyo A; Mpasa A; Huibers MHW; Manda G; Tomoka T; Mulenga M; Namazzi R; Mehta P; Zobeck M; Mzikamanda R; Chintagumpala M; Allen C; Nuchtern JG; Borgstein E; Aronson DC; Ozuah N; Nandi B; McAtee CL
    Pediatr Blood Cancer; 2023 May; 70(5):e30242. PubMed ID: 36798020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wilms tumour in Malawi: surgical staging to stratify postoperative chemotherapy?
    Borgstein E; Kamiza S; Vujanic G; Pidini D; Bailey S; Tomoka T; Banda K; Kaspers G; Molyneux E; Israels T
    Pediatr Blood Cancer; 2014 Dec; 61(12):2180-4. PubMed ID: 25213396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
    Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
    Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of children with a Wilms tumor in Malawi, sub-Saharan Africa.
    Israels T; Borgstein E; Pidini D; Chagaluka G; de Kraker J; Kamiza S; Molyneux EM
    J Pediatr Hematol Oncol; 2012 Nov; 34(8):606-10. PubMed ID: 22767130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
    Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM
    J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of treatment outcome of Wilms Tumour in low-income country; single centre experience from Pakistan.
    Ghafoor T; Bashir F; Ahmed S; Khalil S; Farah T
    J Pediatr Urol; 2020 Jun; 16(3):375.e1-375.e7. PubMed ID: 32224063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age is not a prognostic factor in children with Wilms tumor beyond stage I in Africa.
    Aronson DC; Hadley GP
    Pediatr Blood Cancer; 2014 Jun; 61(6):987-9. PubMed ID: 24453084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival of children with a Wilms tumor in Blantyre, Malawi.
    Israels T; Pidini D; Borgstein E; Bailey S; Tump C; Chagaluka G; Kamiza S; Molyneux E
    Pediatr Hematol Oncol; 2018 Apr; 35(3):196-202. PubMed ID: 30239249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wilms tumor treatment protocol compliance and the influence on outcomes for children in Tanzania.
    Wesevich A; Mocha G; Kiwara F; Chao C; Shabani I; Igenge JZ; Schroeder K
    Pediatr Blood Cancer; 2023 Dec; 70(12):e30704. PubMed ID: 37789508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.
    Fernandez CV; Mullen EA; Chi YY; Ehrlich PF; Perlman EJ; Kalapurakal JA; Khanna G; Paulino AC; Hamilton TE; Gow KW; Tochner Z; Hoffer FA; Withycombe JS; Shamberger RC; Kim Y; Geller JI; Anderson JR; Grundy PE; Dome JS
    J Clin Oncol; 2018 Jan; 36(3):254-261. PubMed ID: 29211618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of children with Wilms tumor treated on a SIOP WT 2001 protocol in a tertiary care hospital in south India.
    John R; Kurian JJ; Sen S; Gupta MK; Jehangir S; Mathew LG; Mathai J
    J Pediatr Urol; 2018 Dec; 14(6):547.e1-547.e7. PubMed ID: 30017606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Wilms tumor treatment in western Kenya.
    Uittenboogaard A; Njuguna F; Mostert S; Langat S; van de Velde ME; Olbara G; Vik TA; Kaspers GJL
    Pediatr Blood Cancer; 2022 Apr; 69(4):e29503. PubMed ID: 34908225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial.
    Pritchard-Jones K; Bergeron C; de Camargo B; van den Heuvel-Eibrink MM; Acha T; Godzinski J; Oldenburger F; Boccon-Gibod L; Leuschner I; Vujanic G; Sandstedt B; de Kraker J; van Tinteren H; Graf N;
    Lancet; 2015 Sep; 386(9999):1156-64. PubMed ID: 26164096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and Clinical Outcomes of Children With Wilms' Tumour: A 15-year Experience in a Single Centre in Nigeria.
    Nasir AA; Abdur-Raheem NT; Abdur-Rahman LO; Ibiyeye TT; Sayomi TO; Adedoyin OT; Adeniran JO
    J Pediatr Surg; 2024 May; 59(5):1009-1014. PubMed ID: 38184433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephron sparing surgery (NSS) for unilateral wilms tumor (UWT): the SIOP 2001 experience.
    Wilde JC; Aronson DC; Sznajder B; Van Tinteren H; Powis M; Okoye B; Cecchetto G; Audry G; Fuchs J; Schweinitz DV; Heij H; Graf N; Bergeron C; Pritchard-Jones K; Van Den Heuvel-Eibrink M; Carli M; Oldenburger F; Sandstedt B; De Kraker J; Godzinski J
    Pediatr Blood Cancer; 2014 Dec; 61(12):2175-9. PubMed ID: 25156758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative chemotherapy for patients with Wilms tumor in Malawi is feasible and efficacious.
    Israëls T; Molyneux EM; Caron HN; Jamali M; Banda K; Bras H; Kamiza S; Borgstein E; de Kraker J
    Pediatr Blood Cancer; 2009 Oct; 53(4):584-9. PubMed ID: 19533658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete necrosis induced by preoperative chemotherapy in Wilms tumor as an indicator of low risk: report of the international society of paediatric oncology (SIOP) nephroblastoma trial and study 9.
    Boccon-Gibod L; Rey A; Sandstedt B; Delemarre J; Harms D; Vujanic G; De Kraker J; Weirich A; Tournade MF
    Med Pediatr Oncol; 2000 Mar; 34(3):183-90. PubMed ID: 10696124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges and outcome of Wilms' tumour management in a resource-constrained setting.
    Wilde JC; Lameris W; van Hasselt EH; Molyneux EM; Heij HA; Borgstein EG
    Afr J Paediatr Surg; 2010; 7(3):159-62. PubMed ID: 20859020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wilms' tumor--lessons and outcomes--a 25-year single center UK experience.
    Fawkner-Corbett DW; Howell L; Pizer BL; Dominici C; McDowell HP; Losty PD
    Pediatr Hematol Oncol; 2014 Aug; 31(5):400-8. PubMed ID: 24933082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A higher tumor volume and undernutrition at diagnosis adversely affect the survival of children with Wilms tumor: A study of 200 patients.
    Rahiman EA; Trehan A; Jain R; Menon P; Kakkar N; Srinivasan R; Sodhi KS; Saxena AK; Kapoor R; Bansal D
    Pediatr Blood Cancer; 2022 Nov; 69(11):e29880. PubMed ID: 35841309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.